These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6141187)

  • 1. Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate.
    Hogarty GE; Munetz MR
    J Clin Psychopharmacol; 1984 Feb; 4(1):17-24. PubMed ID: 6141187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akinesia and postpsychotic depression: a difficult differential diagnosis.
    Siris SG
    J Clin Psychiatry; 1987 Jun; 48(6):240-3. PubMed ID: 2884213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.
    Mandel MR; Severe JB; Schooler NR; Gelenberg AJ; Mieske M
    Arch Gen Psychiatry; 1982 Feb; 39(2):197-203. PubMed ID: 6121543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Postpsychotic depression" and residual schizophrenia in a mental health hospital.
    Mauri MC; Laini V; Barone R; Clemente A; Volonteri LS; Cerveri G; Steinhilber C; Fornier M
    Encephale; 2000; 26(6):21-6. PubMed ID: 11217534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon.
    Bermanzohn PC; Siris SG
    J Clin Psychiatry; 1994 Nov; 55(11):488-91. PubMed ID: 7989282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany].
    Vogel M; Köhnlein O; Schmauss M; Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S173-4. PubMed ID: 15570544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressant treatment of schizophrenic patients].
    Caroli F; Baldacci-Epinette C; Ribeyre P
    Encephale; 1993 Jul; 19 Spec No 2():393-6. PubMed ID: 7904237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
    Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral toxicity of antipsychotic drugs.
    Van Putten T; Marder SR
    J Clin Psychiatry; 1987 Sep; 48 Suppl():13-9. PubMed ID: 2887552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A; Dwolatzky T; Lerner V
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Chen ZH; Wang GH; Wang XP; Chen RY; Wang HL; Yang MH; Huo YX; Mei HB
    Hum Psychopharmacol; 2008 Aug; 23(6):465-70. PubMed ID: 18536066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.